{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:44:36Z","timestamp":1783593876716,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-023-01177-x","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:02:57Z","timestamp":1705924977000},"page":"444-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF\/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-6135","authenticated-orcid":false,"given":"Kathryn","family":"Corbett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2403-1202","authenticated-orcid":false,"given":"Dean","family":"Ruether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-3159","authenticated-orcid":false,"given":"Isolde","family":"Seiden-Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9360","authenticated-orcid":false,"given":"Gregory","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","first-page":"bcr2014205491","DOI":"10.1136\/bcr-2014-205491","volume":"2014","author":"TEN Lo","year":"2014","unstructured":"Lo TEN, Villafuerte CV, Acampado LT (2014) Overwhelming hypercalcemia in mandibular ameloblastoma. BMJ Case Rep 2014:bcr2014205491. https:\/\/doi.org\/10.1136\/bcr-2014-205491","journal-title":"BMJ Case Rep"},{"issue":"5","key":"1177_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/path.4317","volume":"232","author":"KJ Kurppa","year":"2014","unstructured":"Kurppa KJ, Cat\u00f3n J, Morgan PR, Ristim\u00e4ki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K (2014) High frequency of BRAF V600E mutations in ameloblastoma. J Pathol 232(5):492\u2013493. https:\/\/doi.org\/10.1002\/path.4317","journal-title":"J Pathol"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"10585410","DOI":"10.1016\/j.oraloncology.2022.105854","volume":"128","author":"Z Abramson","year":"2022","unstructured":"Abramson Z, Dayton OL, Drane WE, Mendenhall WM, Kaye FJ (2022) Managing stage 4 ameloblastoma with dual BRAF\/MEK inhibition: a case report with 8-year clinical follow-up. Oral Oncol 128:10585410. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.105854","journal-title":"Oral Oncol"},{"issue":"1","key":"1177_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/jnci\/dju378","volume":"107","author":"FJ Kaye","year":"2014","unstructured":"Kaye FJ, Ivey AM, Drane WE, Mendenhall WM, Allan RW (2014) Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst 107(1):378. https:\/\/doi.org\/10.1093\/jnci\/dju378","journal-title":"J Natl Cancer Inst"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tripleo.2003.10.003","volume":"97","author":"RA Abdelsayed","year":"2004","unstructured":"Abdelsayed RA, Vartanian RK, Smith KK, Ibrahim NA (2004) Parathyroid hormone-related protein (PTHrP) expression in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:208\u2013219. https:\/\/doi.org\/10.1016\/j.tripleo.2003.10.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"10","key":"1177_CR6","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1210\/jc.2013-2016","volume":"98","author":"PJ Donovan","year":"2013","unstructured":"Donovan PJ, Sundac L, Pretorius CJ, d\u2019Emden MC, McLeod DS (2013) Calcitriol-mediated hypercalcemia: causes and course in 101 patients. J Clin Endocrinol Metab 98(10):4023\u20134029. https:\/\/doi.org\/10.1210\/jc.2013-2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1177_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1210\/jc.2002-021122","volume":"88","author":"MJ Horwitz","year":"2003","unstructured":"Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF (2003) Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88(2):569\u2013575. https:\/\/doi.org\/10.1210\/jc.2002-021122","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1177_CR8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1359\/JBMR.050602","volume":"20","author":"MJ Horwitz","year":"2005","unstructured":"Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Oca\u00f1a A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF (2005) Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2vitamin D. J Bone Miner Res 20(10):1792\u20131803. https:\/\/doi.org\/10.1359\/JBMR.050602","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1177_CR9","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1210\/jc.2014-4250","volume":"100","author":"PJ Donovan","year":"2015","unstructured":"Donovan PJ, Achong N, Griffin K, Galligan J, Pretorius CJ, McLeod DSA (2015) PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab 100(5):2024\u20132029. https:\/\/doi.org\/10.1210\/jc.2014-4250","journal-title":"J Clin Endocrinol Metab"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/EDM-17-0118","volume":"2017","author":"N Asonitis","year":"2017","unstructured":"Asonitis N, Kassi E, Kokkinos M, Giovanopoulos I, Petychaki F, Gogas H (2017) Hypercalcemia of malignancy treated with cinacalcet. Endocrinol Diabetes Metab Case Rep 2017:17\u20130118. https:\/\/doi.org\/10.1530\/EDM-17-0118","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"1177_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","volume":"13","author":"M Broudic-Guibert","year":"2019","unstructured":"Broudic-Guibert M, Blay JY, Vazquez L, Evrard A, Karanian M, Ta\u00efeb S, Hoog-Labouret N, Oukhatar CMA, Boustany-Grenier R, Arnaud A (2019) Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report. J Med Case Rep 13(1):245. https:\/\/doi.org\/10.1186\/s13256-019-2140-6","journal-title":"J Med Case Rep"},{"issue":"3","key":"1177_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/his.13095","volume":"70","author":"ER Fregnani","year":"2017","unstructured":"Fregnani ER, Perez DEdC, Paes de Almeida O, Fonseca FP, Soares FA, Castro-Junior G, Alves FA (2017) BRAF-V600E expression correlates with ameloblastoma aggressiveness. Histopathology 70(3):473\u2013484. https:\/\/doi.org\/10.1111\/his.13095","journal-title":"Histopathology"},{"issue":"7","key":"1177_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.clml.2018.05.008","volume":"18","author":"CHY Cheung","year":"2018","unstructured":"Cheung CHY, Cheng CK, Lau KM, Ip RKL, Chan NCN, Tam THC, Wong RSM, Raghupathy R, Chan NPH, Ng MHL (2018) Prevalence and clinicopathologic significance of BRAF V600E mutation in chinese multiple myeloma patients. Clin Lymphoma Myeloma Leuk 18(7):315\u2013325. https:\/\/doi.org\/10.1016\/j.clml.2018.05.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"1177_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","volume":"6","author":"M Garnett","year":"2004","unstructured":"Garnett M, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6(4):313\u2013319. https:\/\/doi.org\/10.1016\/j.ccr.2004.09.022","journal-title":"Cancer Cell"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01177-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-023-01177-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01177-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:02:43Z","timestamp":1711011763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-023-01177-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1007\/s00223-023-01177-x","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kathryn Corbett, Dean Ruether, and Gregory Kline declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient provided informed and written consent for publication of the case details and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}